陇神戎发(300534.SZ)获得血液透析浓缩液医疗器械注册证

Core Viewpoint - The company, Longshen Rongfa, has received a medical device registration certificate for its blood dialysis concentrate solution from the National Medical Products Administration, indicating a significant regulatory milestone for the company in the healthcare sector [1] Group 1: Product Details - The blood dialysis concentrate solution consists of two parts: A concentrate and B concentrate [1] - A concentrate includes sodium chloride (NaCl), potassium chloride (KCl), calcium chloride (CaCl2·2H2O), magnesium chloride (MgCl2·6H2O), acetic acid (CH3COOH), and dialysis water [1] - B concentrate is composed of sodium bicarbonate (NaHCO3) and dialysis water [1] Group 2: Application Scope - The product is intended for use in the treatment of acute renal failure and chronic renal failure through blood dialysis [1]